Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab

BACKGROUND: Dermatomyositis and polymyositis (DM/PM) are rare, incurable inflammatory diseases that cause progressive muscle weakness and can be associated with increased medical resource use (MRU). When corticosteroid treatment is unsuccessful, patients may receive intravenous immunoglobulin (IVIg)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinicoecon Outcomes Res
Hauptverfasser: Knight, Tyler, Bond, T Christopher, Popelar, Breanna, Wang, Li, Niewoehner, John W, Anastassopoulos, Kathryn, Philbin, Michael
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2017
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5440004/
https://ncbi.nlm.nih.gov/pubmed/28553129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S130992
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge